Otsuka Pharmaceutical India Profile
Key Indicators
- Authorised Capital ₹ 100.00 Cr
as on 18-07-2024
- Paid Up Capital ₹ 18.88 Cr
as on 18-07-2024
- Company Age 12 Year, 2 Months
- Last Filing with ROC 31 Dec 2023
- Revenue 18.03%
(FY 2023)
- Profit 169.34%
(FY 2023)
- Ebitda 303.89%
(FY 2023)
- Net Worth 219.31%
(FY 2023)
- Total Assets -5.26%
(FY 2023)
About Otsuka Pharmaceutical India
The Corporate was formerly known as Claris Otsuka Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 December 2023. It's a company limited by shares with an authorized capital of Rs 100.00 Cr and a paid-up capital of Rs 18.88 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Otsuka Pharmaceutical India Private Limited India is Mandar Patel as COMPANY SECRETARY. Shuichi Takagi, Parag Swadia, and Tatsuaki Okada serve as directors at the Company.
- CIN/LLPIN
U24230GJ2012PTC072692
- Company No.
072692
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Nov 2012
- Date of AGM
21 Mar 2024
- Date of Balance Sheet
31 Dec 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Otsuka Pharmaceutical India Private Limited offer?
Otsuka Pharmaceutical India Private Limited offers a wide range of products and services, including Vitamins & Supplements, Multivitamins.
Who are the key members and board of directors at Otsuka Pharmaceutical India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mandar Patel | Company Secretary | 29-Mar-2022 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shuichi Takagi  | Director | 29-Jan-2024 | Current |
Parag Swadia  | Whole-Time Director | 18-Dec-2018 | Current |
| Tatsuaki Okada | Director | 28-Apr-2022 | Current |
Financial Performance of Otsuka Pharmaceutical India.
Otsuka Pharmaceutical India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.03% increase. The company also saw a substantial improvement in profitability, with a 169.34% increase in profit. The company's net worth Soared by an impressive increase of 219.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Otsuka Pharmaceutical India?
In 2023, Otsuka Pharmaceutical India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Otsuka Pharmaceutical India?
Otsuka Pharmaceutical India has a workforce of 884 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Otsuka Pharmaceutical India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Otsuka Pharmaceutical India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
